Assistance Available for Patients Diagnosed with Multiple Sclerosis
PAF’s Co-Pay Relief (CPR) program can provide direct financial assistance to qualified patients with co-payments, co-insurance or cost-sharing associated with pharmaceutical treatments and/or prescription medications through funds dedicated to specific disease states. We are pleased to announce that the program has received additional grant support for the multiple sclerosis funds and is now accepting applications for new and renewal patients in each. Fund details are provided below:
Multiple Sclerosis: Maximum Annual Award Amount: $7,000
- Patient must be insured by Medicare, Medicaid, or Military Benefits and insurance must cover the medication for which patient seeks assistance
- Patient must have a confirmed diagnosis of Multiple Sclerosis
- Patient must reside and receive treatment in the United States
- Patient’s income must fall below 400% of the Federal Poverty Guideline (FPG) with consideration of the Cost of Living Index (COLI) and the number in the household
For personal assistance with the application process please call us toll free at 800-532-5274 or 866-512-3861 visit our website at Co-pay Relief with access available for patients, providers and pharmacies.
The Co-Pay Relief program may help with all therapeutic and supportive medications, including generic or bioequivalent products, prescribed to treat and/or manage the patient’s disease or condition.
Disclaimer: Enrollment in and financial assistance from any disease-specific fund is provided on a first come, first serve basis to the extent funding is and remains available. PAF will not consider the identity of any physician, provider, supplier of items or services, donor, drug therapy, services or supplies being utilized or the referral source when assessing whether an applicant is qualified for financial assistance from a PAF CPR disease-specific fund. Under no circumstances will PAF recommend or refer an applicant or enrollee to any fund donor, provider, supplier or product.
Copyright Â© 2019 Patient Advocate Foundation, All rights reserved